UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Relationship between hepatitis C virus (HCV) and insulin resistance, endothelial perturbation, and platelet activation in HIV-HCV-coinfected patients under highly active antiretroviral treatment

European journal of clinical microbiology & infectious diseases, 2006-02, Vol.25 (2), p.98-103

2006

Link zum Volltext

Verfügbarkeit prüfen

Two simultaneous hepatitis B virus epidemics among injecting drug users and men who have sex with men in Buenos Aires, Argentina: characterization of the first D/A recombinant from the American continent

Journal of viral hepatitis, 2008-11, Vol.15 (11), p.827-838

2008

Link zum Volltext

Verfügbarkeit prüfen

P20-11. Subtype B/BF recombinants multiple infection in patients with dual-transmission risks by means of Heteroduplex assay

Retrovirology, 2009-10, Vol.6 (S3), p.P381-P381, Article P381

2009

Link zum Volltext

Verfügbarkeit prüfen

Prospective evaluation of in-house polymerase chain reaction for diagnosis of mycobacterial diseases in patients with HIV infection and lung infiltrates

The international journal of tuberculosis and lung disease, 2004-01, Vol.8 (1), p.106

2004

Link zum Volltext

Verfügbarkeit prüfen

Correlation between HIV-1 viral load and cryptococcal capsular polysaccharide concentration: Evaluation in a clinical setting

International journal of infectious diseases, 2010, Vol.14, p.e124-e124

2010

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of human immunodeficiency virus (HIV)-Trypanosoma cruzi co-infection and injectable-drugs abuse in a Buenos Aires health center

Revista argentina de microbiología, 2008-07, Vol.40 (3), p.164

2008

Link zum Volltext

Verfügbarkeit prüfen

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study

The Lancet (British edition), 2008-08, Vol.372 (9639), p.646-655

2008

Link zum Volltext

Verfügbarkeit prüfen

Insulin resistance status is an important determinant of PAI‐1 levels in HIV‐infected patients, independently of the lipid profile

Journal of thrombosis and haemostasis, 2004-03, Vol.2 (3), p.532-534

2004

Link zum Volltext

Verfügbarkeit prüfen

Association between the acquired free protein S deficiency in HIV‐infected patients with the lipid profile levels

Journal of thrombosis and haemostasis, 2004-07, Vol.2 (7), p.1195-1197

2004

Link zum Volltext

Verfügbarkeit prüfen

Randomized Trial to Evaluate Indinavir/Ritonavir versus Saquinavir/Ritonavir in Human Immunodeficiency Virus Type 1–Infected Patients: The MaxCmin1 Trial

The Journal of infectious diseases, 2003-09, Vol.188 (5), p.635-642

2003

Link zum Volltext

Verfügbarkeit prüfen

P28: In vitro replication competence of a hepatitis B genotype D/A recombinant virus: dissimilar biological behaviour regarding its parental genotypes

Journal of viral hepatitis, 2013-09, Vol.20 (s3), p.31-32

2013

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Controlled, Phase II Trial Comparing Escalating Doses of Subcutaneous Interleukin-2 plus Antiretrovirals versus Antiretrovirals Alone in Human Immunodeficiency Virus—Infected Patients with CD4+ Cell Counts ⩾350/mm3

The Journal of infectious diseases, 2000-05, Vol.181 (5), p.1614-1621

2000

Link zum Volltext

Verfügbarkeit prüfen

A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients : the MaxCmin2 trial

Antiviral therapy, 2005-01, Vol.10 (6), p.735-743

2005

Link zum Volltext

Verfügbarkeit prüfen

Role of -675 4G/5G in the plasminogen activator inhibitor-1 gene and -308G/A tumor necrosis factor-α gene polymorphisms in obese Argentinean patients

Genetic testing and molecular biomarkers, 2012-05, Vol.16 (5), p.372

2012

Link zum Volltext

Verfügbarkeit prüfen

Correlations between synthetic peptide-based enzyme immunoassays and immunofluorescence assay for detection of human herpesvirus 8 antibodies in different Argentine populations

Journal of medical virology, 2006-06, Vol.78 (6), p.806-813

2006

Link zum Volltext

Verfügbarkeit prüfen

Relationship between hepatic enzymes and insulin resistance syndrome markers in HIV with lipodystrophy

Hepatology (Baltimore, Md.), 2004-12, Vol.40 (6), p.1475-1476

2004

Link zum Volltext

Verfügbarkeit prüfen

Gastrointestinal tolerability and quality of life in antiretroviral-naïve HIV-1-infected patients: data from the CASTLE study

AIDS care, 2010-06, Vol.22 (6), p.677-686

2010

Link zum Volltext

Verfügbarkeit prüfen

Cutaneous tuberculosis in patients with AIDS

AIDS patient care and STDs, 1997-12, Vol.11 (6), p.443-449

1997

Link zum Volltext

Verfügbarkeit prüfen

Bloodborne and Sexually Transmitted Infections in Drug Users in a Hospital in Buenos Aires, Argentina

Clinical infectious diseases, 2003-12, Vol.37 (Supplement-5), p.S343-S347

2003

Link zum Volltext

Verfügbarkeit prüfen

Peripheral blood CD4+ T-lymphocyte count influences cerebrospinal fluid cellular response in patients with HIV-related cryptococcal meningitis

Journal of the International AIDS Society, 2008-11, Vol.11 (Suppl 1), p.P252-P252

2008

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of indinavir/ritonavir (800/100 mg twice a day) combined with efavirenz in HIV-infected patients

AIDS (London), 2004-02, Vol.18 (3), p.565-567

2004

Link zum Volltext

Verfügbarkeit prüfen

Nocardiosis in patients with human immunodeficiency virus infection

Enfermedades infecciosas y microbiología clínica, 2005-08, Vol.23 (7), p.419-423

2005

Link zum Volltext

Verfügbarkeit prüfen

Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients

Blood coagulation & fibrinolysis, 2003-01, Vol.14 (1), p.15-18

2003

Link zum Volltext

Verfügbarkeit prüfen

Endothelial markers and HIV infection in the era of highly active antiretroviral treatment

Thrombosis research, 2003-05, Vol.110 (2), p.93-98

2003

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of indinavir/ritonavir (800/ 100 mg twice a day) combined with efavirenz in HIV-infected patients

AIDS (London), 2004-02, Vol.18 (3), p.565-567

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(48)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(37)
Adult
(31)
Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Male
(29)
Female
(24)
Infectious Diseases
(24)
Aids/hiv
(15)
Hiv Infections - Drug Therapy
(15)
Biological And Medical Sciences
(13)
Medical Sciences
(12)
Human Immunodeficiency Virus
(11)
Middle Aged
(11)
Hiv
(10)
Human Viral Diseases
(10)
Immunology
(10)
Microbiology
(10)
Viral Diseases
(10)
Antiretroviral Therapy, Highly Active
(9)
Argentina - Epidemiology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Relationship between hepatitis C virus (HCV) and insulin resistance, endothelial perturbation, and platelet activation in HIV-HCV-coinfected patients under highly active antiretroviral treatment

Two simultaneous hepatitis B virus epidemics among injecting drug users and men who have sex with men in Buenos Aires, Argentina: characterization of the first D/A recombinant from the American continent

P20-11. Subtype B/BF recombinants multiple infection in patients with dual-transmission risks by means of Heteroduplex assay

Prospective evaluation of in-house polymerase chain reaction for diagnosis of mycobacterial diseases in patients with HIV infection and lung infiltrates

Correlation between HIV-1 viral load and cryptococcal capsular polysaccharide concentration: Evaluation in a clinical setting

Prevalence of human immunodeficiency virus (HIV)-Trypanosoma cruzi co-infection and injectable-drugs abuse in a Buenos Aires health center

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study

Insulin resistance status is an important determinant of PAI‐1 levels in HIV‐infected patients, independently of the lipid profile

Association between the acquired free protein S deficiency in HIV‐infected patients with the lipid profile levels

Randomized Trial to Evaluate Indinavir/Ritonavir versus Saquinavir/Ritonavir in Human Immunodeficiency Virus Type 1–Infected Patients: The MaxCmin1 Trial

P28: In vitro replication competence of a hepatitis B genotype D/A recombinant virus: dissimilar biological behaviour regarding its parental genotypes

A Randomized, Controlled, Phase II Trial Comparing Escalating Doses of Subcutaneous Interleukin-2 plus Antiretrovirals versus Antiretrovirals Alone in Human Immunodeficiency Virus—Infected Patients with CD4+ Cell Counts ⩾350/mm3

A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients : the MaxCmin2 trial

Role of -675 4G/5G in the plasminogen activator inhibitor-1 gene and -308G/A tumor necrosis factor-α gene polymorphisms in obese Argentinean patients

Correlations between synthetic peptide-based enzyme immunoassays and immunofluorescence assay for detection of human herpesvirus 8 antibodies in different Argentine populations

Relationship between hepatic enzymes and insulin resistance syndrome markers in HIV with lipodystrophy

Gastrointestinal tolerability and quality of life in antiretroviral-naïve HIV-1-infected patients: data from the CASTLE study

Cutaneous tuberculosis in patients with AIDS

Bloodborne and Sexually Transmitted Infections in Drug Users in a Hospital in Buenos Aires, Argentina

Peripheral blood CD4+ T-lymphocyte count influences cerebrospinal fluid cellular response in patients with HIV-related cryptococcal meningitis

Pharmacokinetics of indinavir/ritonavir (800/100 mg twice a day) combined with efavirenz in HIV-infected patients

Nocardiosis in patients with human immunodeficiency virus infection

Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients

Endothelial markers and HIV infection in the era of highly active antiretroviral treatment

Pharmacokinetics of indinavir/ritonavir (800/ 100 mg twice a day) combined with efavirenz in HIV-infected patients

Suchergebnisse filtern